Innovative Medicines & Omics (IMO) is a peer-reviewed and open-access journal that publishes articles on the critical analysis of human health and animal medicine-related original omics research and its applications in innovative medicines.
The journal includes a variety of omics layers, such as genomics, proteomics, epigenomics metabolomics, lipidomics, peptidomics, metagenomics, microbiome, pharmacogenomics, toxicogenomics, etc., with the focus on disease etiology, prevention, treatment, prognosis and monitoring.
Features include original research articles, reviews, case reports, short communications and editorials. Topics of particular interest include, but are not limited to:
- Disease evolution and heterogeneity
- Single-cell sequencing technique
- Circulating tumor cell
- Personalized medicine
- Drug sensitivity screening
- Combination therapy
- Drug resistance
- Disease therapeutic mechanism and marker detection
- Database and web server
- Computational method
- Assisted reproduction
- Embryonic development
- Animal organ regeneration
- Bioproduct and biomaterial
- Novel therapeutic strategies
- High-throughput screening
- Therapeutic targets
- Combinatorial chemistry, parallel synthesis and library design
- Drug delivery
- Advances in key compound classes and therapeutic areas
- Automation and technology
Editor-in-Chief
Prof. Enrico Mini
Emeritus Professor of Medical Oncology,
Department of Health Sciences, University of Florence, Florence, Italy
Prof. Changyuan YU
College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
We welcome researchers and scholars in the related fields to submit manuscripts to IMO. IMO upholds high publishing standards and adheres to rigorous peer review prior to acceptance. Potential authors are encouraged to make submissions through online submission system：
http://journals.accscience.com/index.php/IMO/login
If you have any question about submissions and publications, please contact the Editorial Office at imo.office@accscience.sg.
Warm Regards,
Editorial Office
Innovative Medicines & Omics
AccScience Publishing
